Equities Analysts Set Expectations for INSP FY2024 Earnings

Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) - Leerink Partnrs reduced their FY2024 earnings estimates for Inspire Medical Systems in a research note issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now expects that the company will earn $1.37 per share for the year, down from their previous forecast of $1.38. The consensus estimate for Inspire Medical Systems' current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems' Q2 2025 earnings at $0.40 EPS, Q3 2025 earnings at $0.47 EPS, Q4 2025 earnings at $1.10 EPS, FY2025 earnings at $1.73 EPS and FY2026 earnings at $2.62 EPS.

Other equities analysts have also recently issued research reports about the company. Leerink Partners boosted their price target on Inspire Medical Systems from $167.00 to $197.00 and gave the stock a "market perform" rating in a report on Tuesday, September 10th. Robert W. Baird increased their price objective on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an "outperform" rating in a research note on Tuesday, November 5th. Truist Financial reaffirmed a "buy" rating and issued a $240.00 target price (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Bank of America upgraded shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Finally, Stifel Nicolaus restated a "hold" rating and issued a $200.00 target price (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $233.58.

Inspire Medical Systems Trading Up 1.4 %

NYSE INSP traded up $2.59 on Wednesday, hitting $191.72. 67,593 shares of the company's stock were exchanged, compared to its average volume of 595,082. The stock has a 50-day moving average of $199.01 and a 200-day moving average of $175.73. The stock has a market cap of $5.75 billion, a price-to-earnings ratio of 176.68 and a beta of 1.36. Inspire Medical Systems has a 52 week low of $123.00 and a 52 week high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The firm's quarterly revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.29) EPS.

Institutional Trading of Inspire Medical Systems

Hedge funds have recently added to or reduced their stakes in the stock. SouthState Corp purchased a new position in Inspire Medical Systems in the second quarter valued at approximately $27,000. True Wealth Design LLC purchased a new stake in shares of Inspire Medical Systems during the third quarter worth $30,000. Farther Finance Advisors LLC boosted its holdings in shares of Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company's stock worth $32,000 after acquiring an additional 139 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Inspire Medical Systems by 559.3% in the third quarter. GAMMA Investing LLC now owns 178 shares of the company's stock worth $38,000 after acquiring an additional 151 shares during the period. Finally, Quarry LP grew its position in shares of Inspire Medical Systems by 105.4% in the second quarter. Quarry LP now owns 343 shares of the company's stock valued at $46,000 after purchasing an additional 176 shares in the last quarter. Institutional investors own 94.91% of the company's stock.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the business's stock in a transaction on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now owns 23,140 shares of the company's stock, valued at approximately $5,090,800. The trade was a 3.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.